Related Experiment Videos
Multiple primary cancers: with reference to atomic bomb survivors in Hiroshima
Summary
Multiple primary cancers occurred in 2.3% of patients. Atomic bomb survivors and radiotherapy patients showed a later incidence of second tumors, with no specific organ predilection.
Area of Science:
- Oncology
- Cancer Research
- Radiation Oncology
Background:
- Multiple primary cancers present a complex clinical challenge.
- Understanding risk factors and temporal patterns is crucial for patient management.
Purpose of the Study:
- To investigate the incidence and characteristics of multiple primary cancers.
- To identify potential risk factors, including atomic bomb exposure and radiotherapy.
Main Methods:
- Retrospective analysis of 44 patients with multiple primary cancers treated between 1968-1981.
- Evaluation of tumor incidence, patient history (atomic bomb exposure, radiotherapy), and tumor site.
Main Results:
- An incidence of 2.3% for multiple primary cancers was observed.
- Nine patients were atomic bomb survivors, developing second tumors approximately 30 years post-exposure.
- Radiotherapy for the first tumor was associated with a later development of the second tumor.
Conclusions:
- Multiple primary cancers have a low but significant incidence.
- Atomic bomb survivors and radiotherapy recipients represent specific subgroups with delayed second tumor development.
- No specific organ sensitivity to radiation was identified for secondary tumor development beyond the thyroid.